Log in

Lotus Eye Hospital and Institute

NSE: LOTUSEYE · ISIN INE947I01017 · Healthcare

₹103.99+0.00 (+0.00%)

Monday 9 November, 12:05 IST. Delayed. Source: Yahoo Finance.

Price chart

₹103.99 +0.00 (+0.00%) today

The day

Previous close
₹103.99
Open
₹104.00
Day high
₹106.80
Day low
₹103.00

Listed on NSE since 11 July 2008.

Key numbers

Market value
₹216.26 Cr
P/E (trailing)
1,299.88
EPS (trailing)
₹0.08
Price to book
3.68
Dividend yield
0.00%
Debt to equity
0.26
Profit margin
0.3%
Beta
0.60
Volume today
3,608
Average volume
15,720

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Revenue and profit

Annual revenue and profit
YearRevenueNet profitEPS
FY23₹45.98 Cr₹4.08 Cr₹1.96
FY24₹47.24 Cr₹2.91 Cr₹1.40
FY25₹48.60 Cr₹73.93 L₹0.36
FY26₹52.48 Cr₹8.04 L₹0.04

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Quarterly results

Results for each quarter, latest first
QuarterRevenueNet profitEPSProfit vs year ago
Q1 FY27Apr–Jun 2026₹17 Cr₹61.37 L₹0.30+12.6%
Q4 FY26Jan–Mar 2026Audited₹14 Cr₹-31.95 L₹-0.15−226.6%
Q3 FY26Oct–Dec 2025₹14 Cr₹-26.07 L₹-0.13–
Q2 FY26Jul–Sep 2025₹13 Cr₹11.58 L₹0.06–
Q1 FY26Apr–Jun 2025₹14 Cr₹54.48 L₹0.26–
Q4 FY25Jan–Mar 2025Audited₹12 Cr₹25.23 L₹0.12–

Source: Lotus Eye Hospital and Institute’s results filed with NSE, standalone (the company alone). Net profit is the share of Lotus Eye Hospital and Institute’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Balance sheet

What the company owns and owes, latest first
As onMarch 2026September 2025March 2025
Fixed assets₹59 Cr₹48 Cr₹49 Cr
Inventories₹4 Cr₹4 Cr₹4 Cr
Owed by customers₹1 Cr₹1 Cr₹1 Cr
Cash and equivalents₹2 Cr₹1 Cr₹2 Cr
Total assets₹83 Cr₹72 Cr₹70 Cr
Borrowings₹11 Cr₹0₹0
Total liabilities₹22 Cr₹11 Cr₹10 Cr
Shareholders’ equity₹60 Cr₹61 Cr₹60 Cr

Source: Lotus Eye Hospital and Institute’s half-yearly statements of assets and liabilities filed with NSE, standalone. Companies file these every September and March.

About Lotus Eye Hospital and Institute

Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch-free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery treatments. It provides treatment services for various eye problems, such as refractive errors, cataract, glaucoma, retinal disease/diabetic eye care, neuro ophthalmology, binocular vision, and corneal infections, as well as various eye-related courses. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 1989 and is based in Coimbatore, India.

Industry
Medical Care Facilities
Based in
Coimbatore
Employees
402

Company website · Profile: Yahoo Finance

In the news

All news

No headlines name Lotus Eye Hospital and Institute in the last day or two.

Dividends and corporate actions

All companies
  • Annual General Meeting

    Action · ex-date 18 September 2023

  • Dividend - Re 0.50 Per Share

    Dividend · ex-date 18 September 2023

  • Annual General Meeting/Dividend - Re 0.50 Per Sh

    Dividend · ex-date 8 September 2022

  • Annual General Meeting/Dividend - Rs 0.50 Per Share

    Dividend · ex-date 8 September 2021

  • Annual General Meeting

    Action · ex-date 19 November 2020

  • Annual General Meeting

    Action · ex-date 16 September 2019

  • Annual General Meeting/Dividend Re 0.5 Per Share

    Dividend · ex-date 14 September 2018

  • Annual General Meeting/Dividend Re 0.5 Per Share

    Dividend · ex-date 14 September 2018

Source: NSE. Latest first, 8 of 18.

Information only, not investment advice. Prices are delayed.

ShareWhatsAppTelegram

Open inZerodha ↗Groww ↗For convenience only: no referral, not a recommendation.